Vivostat A/S Revenue and Competitors

Alleroed,

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Vivostat A/S's estimated annual revenue is currently $5M per year.(i)
  • Vivostat A/S's estimated revenue per employee is $251,000

Employee Data

  • Vivostat A/S has 20 Employees.(i)
  • Vivostat A/S grew their employee count by -9% last year.

Vivostat A/S's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.1M49-18%$10MN/A
#2
$30.4M12129%N/AN/A
#3
$139.8M913-3%$200KN/A
#4
$84.1M0N/A$1.2MN/A
#5
$43.4M17330%N/AN/A
#6
$64.5M25712%N/AN/A
#7
$64.3M20526%$129.6MN/A
#8
$19.6M78-7%N/AN/A
#9
$65.8M2627%N/AN/A
#10
$73.7M23520%$115.5MN/A
Add Company

What Is Vivostat A/S?

Vivostat® develop, manufacture and market the Vivostat® system, which is sold through direct sales channels and distributors throughout Europe, Asia and the Middle East. The uniqueness of the Vivostat® system is a novel patented biotechnological process that enables reliable and reproducible preparation of autologous Fibrin Sealant or Platelet Rich Fibrin (PRF®) to prevent/stop bleeding or stimulate the healing of chronic wounds. With the Vivostat® system It is also possible to co-deliver a desired antibiotic with Vivostat® Fibrin Sealant or Vivostat PRF®. The fully automated Vivostat® system consists of three components: 1. The Processor Unit The Processor Unit is used to process the patient's blood and prepare the Vivostat® Fibrin Sealant or Vivostat PRF® solution. 2. The Applicator Unit The Applicator Unit controls the delivery of the Vivostat® solution to the site of treatment. 3. The Disposable Set The single-use set contains all components needed for preparation and application of Vivostat® Fibrin Sealant or Vivostat PRF®. It is available with a range of application devices each optimised for different types of applications. The Vivostat® system can be used in many clinical applications including but not limited to; cardiac, thoracic, orthopedic and neurosurgery as well as in wound healing treatment. For more information on the Vivostat® system visit the company website at: http://www.vivostat.com/products For questions or inquiries contact Vivostat by e-mail at: [email protected] If you want to be a distributor please go to http://www.vivostat.com/your-contact and find a contact in your area

keywords:N/A

N/A

Total Funding

20

Number of Employees

$5M

Revenue (est)

-9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Vivostat A/S News

2022-04-19 - Vascular Sealant Market Size, Scope And Forecast ...

... Mallinckrodt Inc., TENAXIS MEDICAL INC., Becton Dickinson and Company (Davol Inc.), MEDTRONIC INC., VIVOSTAT A/S, Johnson & Johnson.

2022-04-17 - Medical Adhesive Market Growth Analysis, Recent ...

... Chemence, Baxter, Vivostat A/S, Gem srl, Dentsply Sirona, GluStitch, H.B. Fuller Company., CryoLife, Inc, DuPont and 3M among others.

2022-04-17 - Medical Adhesive Market| Production, Supply and Demand ...

... Vivostat A/S, Gem srl, Dentsply Sirona, GluStitch, H.B. Fuller Company., CryoLife, Inc, Dowdupont and 3M and among other domestic and global players.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.6M49-2%N/A